AurumNews - The Aurum Institute

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Naicker, V., Laher, F., Bekker, L.G., Seaton, K.E., Allen, M., De Rosa, S., Yates, N.L., Mkhize, N.N., Saunders, K., Heptinstall, J. and Malahleha, M., 2024. Safety and immunogenicity after a 30-month...
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-imp

Myers, H., Chongo, B., Zifodya, J.S., Zacaria, I., Machava, E., Simango, A., Amorim, G., Mavume-Mangunyane, E., Chiau, R., Kampa, K.T. and Madede, T., 2024. Implementation of spirometry screening for ...
Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial

Bennett, C., Hoosain, Z., Koen, A., Lalloo, U., Louw, C., Maluleke, V., Patel, F., Benade, G., Venter, E.L., Galbiati, S. and Shinde, V., 2024. Immunogenicity and safety of SARS-CoV-2 recombinant spik...
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

Huang, Y., Alam, S., Andersen-Nissen, E., Carpp, L.N., Dintwe, O.B., Flach, B.S., Grunenberg, N., Laher, F., De Rosa, S.C., Ferrari, G. and Innes, C., 2024. Non-HIV Vaccine-Induced Immune Responses as...
Geospatial correlations and variations in child mortality and stunting in South Africa: Evaluating distal vs structural determinants.

Wand, H., Moodley, J., Reddy, T. and Naidoo, S., 2024. Geospatial Correlations and Variations in Child Mortality and Stunting in South Africa: Evaluating Distal vs Structural Determinants. Spatial an...
Navigating complex care pathways-healthcare workers' perspectives on health system barriers for children with tuberculous meningitis in Cape Town, South Africa.

Baloyi, D.P., Myburgh, H., Bester, D., Anthony, M.G., Switala, J., Schaaf, H.S., Naidoo, L., Solomons, R., Nuttall, J., Murray, J. and Rohlwink, U., 2024. Navigating complex care pathways–healthcare...
Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.

Hamada, Y., Quartagno, M., Malik, F., Ntshamane, K., Tisler, A., Gaikwad, S., Acuna‐Villaorduna, C., Bhavani, P.K., Alisjahbana, B., Ronacher, K. and Apriani, L., 2024. Prevalence of non‐communica...
Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.

Nguyen, L., Leach, A., Piwowar-Manning, E., Marzinke, M., Levesque, A., Gregorio, C., Skinner, K., Towindo, T., Hanes, H., Sarpong, K. and Kasongo, C., 2024. Strengthening the Application of the DAIDS...
Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Stejskal, L., Thistlethwaite, A., Ramirez-Bencomo, F., Rashmi, S., Harrison, O., Feavers, I.M., Maiden, M.C., Jerse, A., Barnes, G., Chirro, O. and Chemweno, J., 2024. Profiling IgG and IgA antibody r...
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Bekker, L.G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G. and Kiwanuka, N., 2024. Twice-yearly lenacapavir or daily F/TAF for HIV...
Prevalence and associated risk factors of chlamydia and gonorrhoea infections among men who have sex with men in Durban, South Africa.

Mofolorunsho, K.C., Mabaso, N., Nundlall, N., Nightingale, A., Nyirenda, M. and Abbai, N., 2024. Prevalence and associated risk factors of chlamydia and gonorrhoea infections among men who have sex wi...
Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine.

Chihana, R., Kee, J.J., Moodie, Z., Huang, Y., Janes, H., Dadabhai, S., Roxby, A.C., Allen, M., Kassim, S., Naicker, V. and Innes, C., 2024. Factors associated with reactogenicity to an investigationa...
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.

Rodriguez, C.A., Natukunda, E., Strehlau, R., Venter, E.L., Rungmaitree, S., Cunningham, C.K., Lalloo, U., Kosalaraksa, P., HellstrÖm, E., Liberty, A. and McGrath, E.J., 2024. Pharmacokinetics and sa...
Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines).

Hansen, M.A., Lekodeba, N.A., Chevalier, J.M., Ockhuisen, T., del Rey-Puech, P., Marban-Castro, E., Martínez-Pérez, G.Z., Shilton, S., Hassan, M.R.A., Getia, V. and Weinert-Mizuschima, C., 2024. Cos...
Understanding the impact of women's correct risk perception on human immunodeficiency virus diagnosis: Insights from South Africa.

Wand, H., Moodley, J., Reddy, T. and Naidoo, S., 2024. Understanding the impact of women’s correct risk perception on human immunodeficiency virus diagnosis: Insights from South Africa. Internation...
Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Fwambah, L., Andisi, C., Streatfield, C., Bromell, R., Hare, J., Esbjörnsson, J., Ndung’u, T., Sanders, E.J., Hassan, A.S. and Nduati, E., 2024. Exposure to common infections may shape basal immuni...
The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer

The Aurum Institute Board is thrilled to announce Prof. Vinodh Edward's appointment as the new Group Chief Operating Officer (GCOO), effective 1 January 2025. This strategic move marks a significant m...
World TB Day 2025: Mothers and Children at the Heart of TB Prevention

When Cyprion Mpume Makhanya learned about the DOLPHIN Moms clinical trial, she was pregnant with her daughter and fearful of the unknown. Could participating in the study really protect her baby from ...
Aurum's OP Team Showcases Best Practices at PHASA 2025

The annual Public Health Association of South Africa (PHASA) Conference took place from 6–9 April in Worcester, convening public health professionals from across South Africa, the continent, and bey...
Driving scalable, secure innovation in a decade-long ICT partnership between The Aurum Institute and Datacentrix

...

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-imp

Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

Geospatial correlations and variations in child mortality and stunting in South Africa: Evaluating distal vs structural determinants.

Navigating complex care pathways-healthcare workers' perspectives on health system barriers for children with tuberculous meningitis in Cape Town, South Africa.

Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.

Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.

Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Prevalence and associated risk factors of chlamydia and gonorrhoea infections among men who have sex with men in Durban, South Africa.

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine.

Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.

Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines).

Understanding the impact of women's correct risk perception on human immunodeficiency virus diagnosis: Insights from South Africa.

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer

World TB Day 2025: Mothers and Children at the Heart of TB Prevention

Aurum's OP Team Showcases Best Practices at PHASA 2025

Driving scalable, secure innovation in a decade-long ICT partnership between The Aurum Institute and Datacentrix

Popular Tags

Most Read

Recent Posts